Estados financieros detallados de Biomea Fusion, Inc. (BMEA): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $1.74, BMEA presenta beneficios negativos (P/E no significativo) y un ROE del -171.19%. La capitalización bursátil es de $126M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | $132000 | 0 | 0 | 0 | 0 | $1.4M |
| Beneficio Bruto | 0 | -$132000 | 0 | 0 | 0 | 0 | -$1.4M |
| I+D | $1.1M | $3.7M | $28.0M | $62.7M | $102.5M | $118.1M | $62.0M |
| Generales y Administrativos | $103000 | $1.5M | $13.7M | $20.9M | $23.6M | $26.0M | $19.3M |
| Gastos Operativos | $1.2M | $5.2M | $41.7M | $83.6M | $126.1M | $144.1M | $79.9M |
| Beneficio Operativo | -$1.2M | -$5.3M | -$41.7M | -$83.6M | -$126.1M | -$144.1M | -$81.3M |
| EBITDA | -$1.2M | -$5.2M | -$41.3M | -$81.1M | -$115.7M | -$136.7M | -$60.4M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$1.2M | -$5.3M | -$41.6M | -$81.8M | -$117.3M | -$138.4M | -$61.8M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$1.2M | -$5.3M | -$41.6M | -$81.8M | -$117.3M | -$138.4M | -$61.8M |
| BPA | $-0.11 | $-0.50 | $-1.74 | $-2.80 | $-3.44 | $-3.83 | $-1.18 |
| BPA Diluido | $-0.11 | $-0.50 | $-1.74 | $-2.80 | $-3.44 | $-3.83 | $-1.18 |
| Acciones en Circulación (Diluidas) | $10.7M | $10.7M | $23.9M | $29.3M | $34.1M | $36.1M | $52.2M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | -$47000 | -$46000 | 0 |
| Beneficio Operativo | -$20.8M | -$11.7M | -$12.8M | -$12.8M |
| EBITDA | -$18.2M | $4.7M | -$12.4M | -$8.3M |
| Beneficio Neto | -$16.4M | $4.6M | -$12.4M | -$8.3M |
| BPA | $-0.27 | $0.06 | $-0.17 | $-0.12 |
| BPA Diluido | $-0.27 | $0.06 | $-0.17 | $-0.12 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $239000 | $61.7M | $145.7M | $111.9M | $176.9M | $58.3M | $55.8M |
| Inversiones a Corto | 0 | 0 | $27.8M | $1.1M | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $265000 | $62.2M | $176.6M | $117.8M | $179.2M | $68.3M | $58.0M |
| Inmovilizado Material | 0 | $291000 | $5.7M | $8.0M | $14.9M | $10.6M | $153000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $265000 | $62.5M | $185.7M | $129.3M | $199.9M | $79.9M | $58.6M |
| Cuentas por Pagar | $271000 | $727000 | $1.3M | $6.8M | $6.9M | $12.9M | $3.2M |
| Deuda a Corto | 0 | $36000 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $286000 | $1.6M | $4.6M | $19.1M | $22.9M | $21.7M | $11.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $286000 | $57.4M | $6.9M | $20.8M | $30.7M | $28.4M | $29.0M |
| Reservas | -$2.9M | -$8.2M | -$49.7M | -$131.6M | -$248.8M | -$387.3M | -$449.0M |
| Patrimonio Neto | -$21000 | $5.2M | $178.8M | $108.5M | $169.2M | $51.6M | $29.6M |
| Deuda Total | 0 | $259000 | $2.9M | $2.3M | $10.3M | $8.8M | $1.6M |
| Deuda Neta | -$239000 | -$61.4M | -$170.7M | -$110.8M | -$166.6M | -$49.5M | -$54.2M |
| Capital Circulante | -$21000 | $60.6M | $171.9M | $98.7M | $156.3M | $46.7M | $46.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $46.6M | $55.8M | $44.7M | $34.8M |
| Activos Totales | $55.2M | $58.6M | $46.4M | $36.9M |
| Pasivos Totales | $39.6M | $29.0M | $27.7M | $24.7M |
| Patrimonio Neto | $15.6M | $29.6M | $18.7M | $12.1M |
| Deuda Total | $6.9M | $1.6M | $1.2M | $877000 |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$1.2M | -$5.3M | -$41.6M | -$81.8M | -$117.3M | -$138.4M | -$61.8M |
| Amortizaciones | 0 | $132000 | $249000 | $691000 | $1.5M | $1.7M | $1.4M |
| Compensación en Acciones | 0 | 0 | $6.2M | $10.3M | $14.1M | $19.1M | $9.5M |
| Cambio en Capital Circulante | -$81000 | $411000 | -$1.6M | $7.7M | $2.3M | -$5.1M | -$3.7M |
| Flujo de Caja Operativo | -$1.3M | -$4.5M | -$35.4M | -$62.4M | -$96.6M | -$119.9M | -$70.4M |
| Inversiones (CapEx) | 0 | -$51000 | -$3.2M | -$1.0M | -$3.4M | -$362000 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$1.3M | -$4.5M | -$38.6M | -$63.4M | -$100.0M | -$120.3M | -$70.4M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$12.2M | -$13.2M | -$11.7M | -$10.0M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$12.2M | -$13.2M | -$11.7M | -$10.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | 0 | $1.6M | $1.6M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -344.4% | -680.7% | -96.9% | -43.3% | -18.1% | +55.4% |
| Crecimiento BPA (anual) | | -354.5% | -248.0% | -60.9% | -22.9% | -11.3% | +69.2% |
| Cambio en Acciones (anual) | | +0.0% | +122.8% | +22.7% | +16.5% | +5.9% | +44.7% |
| Crecimiento FCF (anual) | | -252.6% | -756.1% | -64.3% | -57.6% | -20.3% | +41.5% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.12 | $-0.42 | $-1.62 | $-2.17 | $-2.93 | $-3.33 | $-1.35 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $10.7M | $10.7M | $23.9M | $29.3M | $34.1M | $36.1M | $52.2M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -171.19% |
| Rentabilidad sobre capital invertido | -212.95% |
| Rentabilidad sobre activos | -88.24% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.07 |
| Ratio corriente | 3.47 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -13.01 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -154.55 | -34.00 | -4.28 | -3.01 | -4.22 | -1.01 | -1.05 |
| P/VC | -8668.42 | 35.22 | 0.99 | 2.27 | 2.93 | 2.72 | 2.19 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |